Gainers:
Goldman Sachs Group, Inc. (GS) is up 0.56 percent to $125.20. The company swung to a profit in its third quarter and its earnings per share topped Wall Street view. The company also increased its quarterly dividend.
Mattel, Inc. (MAT) is gaining nearly 5 percent to $37.05. The company's third quarter profit and sales improved from the year-ago quarter and were above Wall Street view.
Johnson & Johnson (JNJ) is up 1 percent to $69.40. The company's third quarter profit slipped from the year-ago quarter, but its adjusted earnings per share topped analysts' estimate. Sales to customers improved 6.5 percent.
UnitedHealth Group Inc. (UNH) is rising over 1 percent to $58.24. The company's third quarter earnings improved from the prior year period and also topped analysts' projection. Total revenues improved from the year-ago quarter, but marginally missed the consensus estimate. Meanwhile, the company raised its earnings outlook for 2012.
Domino's Pizza, Inc. (DPZ) is up nearly 4 percent to $39.67. The company's third quarter earnings and sales increased from the year-ago quarter and were above Wall Street view.
Decliners:
Citigroup Inc. (C) is falling over 2 percent to $35.89 following its announcement that Vikram Pandit has stepped down as its chief executive Officer and as a member of the board, effective immediately. The company's board has unanimously elected Michael Corbat as CEO and a director. The company further announced that its president and chief operating officer, John Havens, has resigned.
Clearwire Corp. (CLWR) is down 16 percent to $2.25 amidst reports that Sprint Nextel Corp. (S), which announced a deal to sell 70 percent stake to Japan's Softbank Corp., has no immediate plans to take over the Bellevue, Washington-based company.
Wolverine World Wide, Inc. (WWW) is falling more than 3 percent to $41.87. The company's third quarter profit and revenue declined from the previous year period.
Trading halt:
Trading in shares of NPS Pharmaceuticals, Inc. (NPSP) was halted. The FDA's Gastrointestinal Drugs Advisory Committee is meeting today to review Gattex (teduglutide), a recombinant analog of human glucagon-like peptide 2 being developed for the treatment of adults with short bowel syndrome.
For comments and feedback contact: editorial@rttnews.com
Business News
June 05, 2026 16:18 ET A busy week for economic news flow saw a slew of reports being released that reflected the trends in the U.S. labor market. In Europe, economic growth and inflation data gained attention as the European Central Bank and Bank of England head for policy session later in the month. In Asia, the monetary policy session of the Indian central bank was in focus as the country, a major oil importer, reels under the pressures of a weaker rupee and rising inflation.